Literature DB >> 9721229

Mapping of a neurovirulence determinant within the envelope protein of a polytropic murine retrovirus: induction of central nervous system disease by low levels of virus.

D J Poulsen1, S J Robertson, C A Favara, J L Portis, B W Chesebro.   

Abstract

Murine leukemia virus (MuLV) clone Fr98 is a recombinant polytropic virus that causes neurological disease characterized by ataxia in susceptible mouse strains. The envelope gene of Fr98 has been previously shown to encode at least two separate neurovirulence determinants. In the present study, the determinant encoded within the EcoRI/AvrII fragment of the envelope gene was further defined. In these experiments, neurovirulence was associated with a change from a serine to an arginine at position 195 and a glycine to an alanine at position 198 within the envelope protein. Neurovirulent and nonvirulent virus clones, which differed only at these two amino acid residues, showed no difference in the type or location of cells infected. Furthermore, equivalent levels of viral p30 capsid protein were detected in the brains of mice infected with either the neurovirulent or nonvirulent virus clones. These results were consistent with the interpretation that the envelope protein of the neurovirulent virus differed from that of the nonvirulent virus by having a greater toxic effect on central nervous system function.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9721229     DOI: 10.1006/viro.1998.9258

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  12 in total

1.  Brain infection by neuroinvasive but avirulent murine oncornaviruses.

Authors:  S Asković; F J McAtee; C Favara; J L Portis
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

2.  Neurovirulence of polytropic murine retrovirus is influenced by two separate regions on opposite sides of the envelope protein receptor binding domain.

Authors:  Karin E Peterson; Susan Pourciau; Min Du; Rachel Lacasse; Melissa Pathmajeyan; David Poulsen; Mavis Agbandje-McKenna; Kathy Wehrly; Bruce Chesebro
Journal:  J Virol       Date:  2008-06-25       Impact factor: 5.103

3.  Differences in cytokine and chemokine responses during neurological disease induced by polytropic murine retroviruses Map to separate regions of the viral envelope gene.

Authors:  K E Peterson; S J Robertson; J L Portis; B Chesebro
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

Review 4.  Human immunodeficiency virus type 1 genetic diversity in the nervous system: evolutionary epiphenomenon or disease determinant?

Authors:  Guido van Marle; Christopher Power
Journal:  J Neurovirol       Date:  2005-04       Impact factor: 2.643

Review 5.  Innate immunity in the pathogenesis of polytropic retrovirus infection in the central nervous system.

Authors:  Karin E Peterson; Min Du
Journal:  Immunol Res       Date:  2009       Impact factor: 2.829

6.  Disparate regions of envelope protein regulate syncytium formation versus spongiform encephalopathy in neurological disease induced by murine leukemia virus TR.

Authors:  Samuel L Murphy; Marek J Honczarenko; Natalie V Dugger; Paul M Hoffman; Glen N Gaulton
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

7.  Novel role of CD8(+) T cells and major histocompatibility complex class I genes in the generation of protective CD4(+) Th1 responses during retrovirus infection in mice.

Authors:  Karin E Peterson; Ingunn Stromnes; Ron Messer; Kim Hasenkrug; Bruce Chesebro
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

8.  Human immunodeficiency virus type 1 envelope-mediated neuronal death: uncoupling of viral replication and neurotoxicity.

Authors:  Kunyan Zhang; Farazana Rana; Claudia Silva; Julie Ethier; Kathy Wehrly; Bruce Chesebro; Christopher Power
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

9.  Neuronal death induced by brain-derived human immunodeficiency virus type 1 envelope genes differs between demented and nondemented AIDS patients.

Authors:  C Power; J C McArthur; A Nath; K Wehrly; M Mayne; J Nishio; T Langelier; R T Johnson; B Chesebro
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

10.  Protection against murine leukemia virus-induced spongiform myeloencephalopathy in mice overexpressing Bcl-2 but not in mice deficient for interleukin-6, inducible nitric oxide synthetase, ICE, Fas, Fas ligand, or TNF-R1 genes.

Authors:  Paul Jolicoeur; Chunyan Hu; Tak W Mak; Jean-Claude Martinou; Denis G Kay
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.